Vermont's Community-Oriented All-Payer Medical Home Model Reduces Expenditures and Utilization While Delivering High-Quality Care
Craig Jones(Johns Hopkins University), Jenney Samuelson(Blueprint Medicines (United States)), Timothy Tremblay(Blueprint Medicines (United States)), Karl Finison, Katharine McGraves-Lloyd(Healthpoint), Mary Kate Mohlman(Vermont State Hospital), Beth Tanzman(Vermont Department of Health), Steven Maier(Blueprint Medicines (United States)), Miki Hazard(Blueprint Medicines (United States))
Cited by 32
Related Papers
MRI detection of glycogen <i>in vivo</i> by using chemical exchange saturation transfer imaging (glycoCEST)
|Proceedings of the National Academy of Sciences|2007|417
Effects of signal‐to‐noise ratio on the accuracy and reproducibility of diffusion tensor imaging–derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T
|Journal of Magnetic Resonance Imaging|2007|371
Amide proton transfer imaging of human brain tumors at 3T
|Magnetic Resonance in Medicine|2006|341
Nuclear Overhauser enhancement (NOE) imaging in the human brain at 7T
|NeuroImage|2013|327